Search

everythinglearnresearchcommunity

for

Search:↓

Treating underlying metabolic and hormonal issues is key to managing female hair loss.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Low testosterone levels may contribute to female pattern hair loss in men.

Lower LDL-c levels predict higher COVID-19 mortality.

The woman has scurvy and needs more vitamin C.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

A woman with anorexia improved significantly after being treated for scurvy with vitamin C, despite not showing typical scurvy symptoms.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The study concluded that hair growth in mice is regulated by a stable interaction between skin cell types, and disrupting this can cause hair loss.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

Middle Eastern patients with epidermolysis bullosa show specific genetic mutations linked to different types of the disease.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

Hair health can indicate mental and general health.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Taking iron pills does not improve hair loss treatment in women with low iron compared to using minoxidil alone.

People with Telogen Effluvium often lack vitamin D, ferritin, and zinc.

Vitamin supplements may not improve hair thickness or density in patients with non-scarring hair loss.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

Dr. Shyam B Verma encourages more scientific research on hair disorders and criticizes the unscientific hair care market in India.